Dmitry Gabrilovich

Dmitry Gabrilovich is an established scientist in the field of cancer immunology, currently serving as Executive Director and Chief Scientist at AstraZeneca since June 2020, where focus includes investigating myeloid cell function in cancer and developing targeted therapies. Prior to this role, Dmitry held a professorship at The Wistar Institute from May 2013 to June 2020 and served as both Associate Professor and Professor at H. Lee Moffitt Cancer Center and Research Institute from September 2000 to April 2013. Additional academic experience includes positions as Assistant Professor at Loyola University Chicago Stritch School of Medicine and Research Assistant Professor and Instructor at Vanderbilt University School of Medicine.